This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
Study Description A5384 is a trial for people who have or might have tuberculous meningitis (TBM). TBM is an infectious disease...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
